Cargando…

While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?

At the time of reception of this article (April 2, 2020), efforts to develop a specific vaccine against SARS-Cov-2, the causative agent of the coronavirus disease 2019 (COVID-19), had just begun trial phase 1, but full validation of this and other current developments is likely to take many more mon...

Descripción completa

Detalles Bibliográficos
Autor principal: Barrantes, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350707/
https://www.ncbi.nlm.nih.gov/pubmed/32719619
http://dx.doi.org/10.3389/fphys.2020.00820